Research on the trials that test new treatments in patients. Covers trial design, respiratory and cancer trials, screening tools, and treatment breakthroughs.
A phase II clinical trial showed that combining radiation, chemotherapy, and immunotherapy can shrink tumors and allow surgery, resulting in significantly improved outcomes. The study found that patients who underwent surgery had a 82% reduction in risk of death at one year follow-up.
A new study found that standardized autism screening during pediatric well-child visits identifies more children with high autism likelihood at a younger age. The study used the Modified Checklist for Autism in Toddlers, Revised, with Follow-Up (M-CHAT-R/F) and compared it to usual care.
Researchers found semaglutide and liraglutide substantially decrease AUD hospitalization risk compared to approved medications. Clinical trials are needed to confirm these findings and explore their efficacy in treating AUD.
A randomized clinical trial shows cognitive behavioral therapy for prolonged grief outperforms present-centered therapy in treating comorbid symptoms, while both treatments demonstrate effectiveness and acceptability. The findings suggest potential for dissemination and increased patient choice.
Patients receiving MRI-guided SBRT experienced significantly fewer urinary and bowel side effects compared to CT-guided treatment. MRI guidance also correlated with improved scores on specific quality-of-life measures, including bowel function and sexual health.
Singer Amy Grant's personal testimonial highlights the urgent need for support to save women's lives by funding research into better diagnosing, treating, and preventing cardiovascular disease. The American Heart Association aims to address awareness gaps and bridge clinical care gaps in women's heart health.
The new hospital will provide patient-centered care with personalized, compassionate treatment and groundbreaking research. Patients will have access to top specialists and pioneering therapies in cancer treatment.
The London Health Sciences Centre was the first and only hospital in Canada to implant a new extravascular implantable cardioverter defibrillator (ICD) during clinical trials. The device has been shown to provide long-term safety, efficacy, and performance, offering better comfort and care for patients.
A new clinical trial found that the addition of immunotherapy drug pembrolizumab to standard treatment improved disease-free survival rates for patients with stage 3 soft tissue sarcoma. The study showed that pembrolizumab reduced recurrence or death for patients by 15 percentage points compared to standard treatment.
Researchers at UCLA Health Jonsson Comprehensive Cancer Center have shown that combining pembrolizumab, an immunotherapy drug, with standard chemotherapy can improve treatment outcomes for patients with advanced small cell bladder cancer and small cell/neuroendocrine prostate cancer. The study found that the combination treatment resul...
A new study published in JAMA Network Open found that brief cognitive behavioral therapy via video telehealth reduces suicide attempts and suicidal ideation, providing critical insight into treatment options for those struggling with suicidal thoughts. The study also shows that this therapy is effective in reducing depressive symptoms.
Researchers found that non-invasive stereotactic radiosurgery significantly improves tumor control and reduces symptoms such as tinnitus, cranial nerve deterioration, and vestibular dysfunction. Early treatment can prevent tumors from growing over time and spare patients from irreversible problems.
The Phase IIa trial of ISM001-055 showed dose-dependent improvement in forced vital capacity (FVC) and percent predicted FVC, suggesting potential to slow or reverse disease progression. The treatment also demonstrated a favorable pharmacokinetics profile with minimal adverse events.
The VANCE trial demonstrates that Singapore has the expertise and capabilities to run large-scale global cell therapy trials. The study shows promising results for patients with recurrent or metastatic NPC treated with EBV-CTL therapy, with median survival rates of up to 29.9 months.
The ISSCR has developed a comprehensive Continuing Education (CE) course on stem cell-based therapies, covering fundamental biology, clinical trials, and patient communication. The open-access course aims to equip healthcare providers with accurate information, empowering them to navigate the complexities of this evolving field.
Researchers at MD Anderson Cancer Center present promising new treatments, including a gastric cancer therapy using T cell antigen coupler technology. Additionally, COVID-19 mRNA vaccines are shown to improve responses to immune checkpoint inhibitors in patients with non-small cell lung and melanoma cancers.
University of Cincinnati researchers highlight the importance of emergency consent in acute stroke trials due to time-sensitive nature and high mortality rate. They argue for more efficient alternatives to traditional informed consent, emphasizing patient autonomy and beneficence.
A new study published in The British Journal of Cancer found that whole genome sequencing can help identify treatment recommendations for cancer patients. The study evaluated the regional implementation of the 100,000 Genomes Project and found that different types of cancer were associated with varying rates of recommended actions.
Researchers at UCSD found psilocybin therapy reduces eating disorder psychopathology and improves quality-of-life in patients with anorexia nervosa, but results vary widely among individuals. Genetic variations may influence treatment outcomes.
Rice bioengineers create a mathematical model that challenges long-held assumptions about IL-12's behavior in the body, suggesting repeated doses cause immune cells to hoard IL-12 before it reaches the bloodstream. The findings have significant implications for IL-12 therapy design and may lead to more effective dosing regimens.
A randomized clinical trial found that simultaneous administration of mRNA COVID-19 and inactivated influenza vaccines had comparable reactogenicity to sequential administration. This suggests a safe option for co-administration of these vaccines.
A multicenter national clinical trial is being conducted to study whether giving antibiotics at the start of labor induction can decrease C-sections in pregnant women with obesity. The trial aims to enroll nearly 800 women and analyze infection rates, complications, and microbiome changes.
A phase 2 clinical trial found that the combination of vidutolimod and nivolumab led to tumor control in 55% of patients, with higher levels of immune-related proteins detected in responders. The study also uncovered unique signatures of TLR9 activation and a link between gut microbiome and response to therapy.
Researchers found that both methods restored blood circulation in about 30% of patients, with no difference in survival or quality of life. The study's results may impact future guidelines for cardiac arrest treatment.
Researchers synthesizing AI with biomarker analysis aim to detect early signs of aging and enable targeted interventions to delay disease. This approach has the potential to slow, prevent or reverse certain effects of aging.
A post hoc analysis of the ARCADIA trial found no significant difference in major ischemic and hemorrhagic events between apixaban and aspirin in patients with a history of cancer and cryptogenic stroke. The study suggests that both treatments may be effective, but further research is needed to confirm these results.
The NoNO Trial, a seven-year randomized controlled trial, aims to study the efficacy of using nitric oxide in treating congenital diaphragmatic hernia (CDH) in newborns. The study will compare outcomes before and after de-implementation of nitric oxide at participating centers.
A study led by WVU epidemiologist Bethany Barone Gibbs found that alternating sitting and standing at work reduces sedentary behavior but has no effect on lowering blood pressure. Prolonged static standing may even have negative effects on cardiovascular health due to a physiological mechanism called the muscle pump.
A four-year study funded by a $2.5 million grant will investigate the impact of spinal cord transcutaneous stimulation combined with gait training on motor recovery in individuals with traumatic brain injury. The research aims to improve clinical treatment strategies and decision-making for improved gait and functional recovery.
A study found that using an orbital atherectomy device to remove calcium from blocked coronary arteries before stenting procedures did not improve patient outcomes. The device was used on patients with moderately severe calcification, rather than extreme cases, and did not show significant benefits.
A KAIST team created a face-conforming LED mask with improved efficacy in skin rejuvenation. The FSLED mask demonstrated a 340% improvement in deep skin elasticity compared to conventional masks, showing significant benefits for anti-aging treatment.
Researchers have developed a technology called FarrSight-Twin that creates digital twins of real cancer patients to predict treatment response. The approach was tested on published clinical trials and showed accurate predictions in all simulated studies, with 75% response rate among patients receiving the predicted best treatment.
TYRA-300 shows promise in treating metastatic bladder cancer patients with FGFR3 gene mutations, achieving a 50% overall response rate and 100% disease control rate. The treatment also displays improved tolerability with lower side effects compared to existing pan-FGFR inhibitors.
A cohort study of children with vesicoureteral reflux found that glomerular filtration rate changes after urinary tract infections. The study used data from the Children With Vesicoureteral Reflux trial to assess estimated glomerular filtration rate changes in participants with vs without recurrent UTIs.
The myeloMATCH program offers a portfolio of biomarker-driven treatment trials to accelerate precision medicine in myeloid malignancies. Patients can enroll in clinical trials throughout their cancer treatment journey, with test results returned quickly to assign them to the most appropriate trial.
A new study suggests that MRI can predict patient outcomes and the risk of tumor reccurrence or spread for patients with rectal cancer who have undergone chemotherapy and radiation. This information could help doctors determine the best course of treatment, including whether to spare patients from invasive surgery.
Women who started an aerobic exercise program during chemotherapy reported improved cognitive function and quality of life compared to those receiving standard care. The study found that while cognitive performance was similar after chemotherapy completion, the exercise program had a positive impact on self-reported cognitive function.
A Phase I human clinical trial is commencing to test the efficacy and safety of transplantation of olfactory cell nerve bridges to treat chronic spinal cord injury. The trial combines olfactory ensheathing cells with long-term intensive rehabilitation.
This article provides practical recommendations for improving ethical oversight of clinical trials in the US. Key findings include enhanced regulatory mechanisms and training programs to ensure compliance with existing regulations.
A randomized clinical trial found that montelukast did not shorten the duration of COVID-19 symptoms among outpatients with mild to moderate illness. The study's findings suggest that montelukast is unlikely to be beneficial for treating mild to moderate COVID-19.
A €1.3 million consortium aims to rapidly deploy technology and develop new knowledge to end the Mpox outbreak in DRC and surrounding countries. The project will expand a trial exploring Mpox vaccination effectiveness in additional African countries.
A recent study published in eClinicalMedicine found that a combination of amubarvimab and romlusevimab did not reduce the occurrence of long COVID symptoms. The researchers assessed symptom diaries and health-related quality of life questionnaires, but saw no significant difference between treatment and placebo groups.
The two-year progression-free survival rate was 92% on the N-AVD arm compared to 83% on the BV-AVD arm, with fewer side effects and lower mortality rates. The study's results support the use of nivolumab-AVD as a standard treatment for stage 3-4 classic Hodgkin lymphoma.
A new clinical trial has found that the mpox vaccine is safe and generates an immune response equivalent to adults, providing hope for adolescents affected by the virus. The study's interim results were presented at IDWeek2024 conference in Los Angeles.
A randomised clinical trial shows that integrating physiotherapy and cognitive-behavioural therapy is effective in improving symptoms and physical aspects of the quality of life of patients with functional movement disorders. The study suggests this approach could be cost-effective and opens up new lines of research.
A nationwide clinical trial found that electronic letter-based nudges significantly increased influenza vaccination in young and middle-aged patients with chronic diseases. The results suggest a scalable, cost-efficient strategy to boost public health.
Researchers propose utilizing human 3D skin models to assess drug binding properties across different skin types. Genetic variations among minority groups can lead to starkly different drug responses across races and ethnicities.
The first phase of the Ceramide Ring Trial has been published in Nature Communications, representing a significant landmark in lipidomics. The trial established ceramide reference values, which are essential for understanding the roles of lipids in health and disease.
The study marked a significant milestone in lipidomics, establishing reference values for ceramides and plasma lipids involved in cardiovascular disease risk prediction. The global network of laboratories achieved better-than-anticipated comparability in results using different methods and instrumentations.
A study found that screening frequency and breathing trial techniques did not affect the time to successful extubation. However, a combination of more frequent screening and pressure-supported SBTs increased the time to first successful extubation.
Researchers at Mass General Brigham discovered that combining two therapeutic agents can selectively kill tumor cells in triple negative breast cancer, differentiating them and triggering a process similar to involution. The study provides support for clinical trials testing this new approach.
Industry-sponsored trials have grown while federally funded enrollment remains flat, jeopardizing research in cancer prevention, screening, and health disparities. Diversified funding and strong advocacy are needed to ensure all patient populations benefit from research advancements.
Researchers found that patients had the same success rate when treated for 24 hours compared to 72 hours, with no difference in need for transfusion, ventilation, or vasopressors. This suggests that shorter octreotide therapy may be sufficient and could help reduce hospital stays and costs.
A crossover randomized clinical trial found that using lap or side positions for blood pressure readings leads to substantial overestimation. This misdiagnosis could have serious consequences, particularly for patients with hypertension.
Recent clinical trials of neoadjuvant therapy before radical prostatectomy, such as the ACDC-RP trial, have struggled to show significant survival benefits. Researchers recommend maximal androgen blockade with an androgen receptor pathway inhibitor as the 'backbone' of neoadjuvant therapy trials.
A study found that doxycycline post-exposure prophylaxis (doxy-PEP) did not significantly alter the overall composition of gut bacteria in individuals who took it for six months. However, the researchers noted signs of resistance building against tetracycline, a class of antibiotics to which doxycycline belongs.
A new non-invasive imaging technique has been shown to accurately detect clear-cell renal cell carcinoma, the most common form of kidney cancer. The technique uses a monoclonal antibody drug that targets the protein CA9, highly expressed in up to 95% of clear cell kidney cancers.
A study suggests that online insomnia treatment, SHUTi, can provide meaningful relief for caregivers struggling with sleep difficulties. The program showed promising results in improving sleep quality and reducing stress among high-intensity caregivers, those shouldering the greatest responsibilities in caring for their loved ones.
A randomized phase 3 trial found that extended lymph node removal in bladder cancer surgery does not improve disease-free or overall survival but increases the risk of complications and death. The standard bilateral pelvic lymphadenectomy is considered a sufficient approach for these patients.
Pragmatic clinical trials compare treatments in everyday clinical settings, but adoption of trial findings has been inconsistent. To address this, the authors propose adaptive trial designs to align trial goals with healthcare system needs. By doing so, they aim to generate evidence that truly improves patient care.